NASDAQ: AEMD
Aethlon Medical Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AEMD stock forecasts and price targets.

Forecast return on equity

Is AEMD forecast to generate an efficient return?

Company
-12.19%
Industry
30.01%
Market
181.35%
AEMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AEMD forecast to generate an efficient return on assets?

Company
-10.16%
Industry
15.09%
AEMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AEMD earnings per share forecast

What is AEMD's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$10.78
Avg 2 year Forecast
-$2.25
Avg 3 year Forecast
-$0.51

AEMD revenue forecast

What is AEMD's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

AEMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AEMD$1.70N/AN/A
FEED$2.01N/AN/A
BBLG$1.28N/AN/A
VTAK$1.41N/AN/A
NUWE$1.43N/AN/A

Aethlon Medical Stock Forecast FAQ

What is AEMD's earnings growth forecast for 2026-2028?

(NASDAQ: AEMD) Aethlon Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.44%.

Aethlon Medical's earnings in 2026 is -$11,522,096.On average, 5 Wall Street analysts forecast AEMD's earnings for 2026 to be -$14,172,020, with the lowest AEMD earnings forecast at -$13,828,908, and the highest AEMD earnings forecast at -$14,361,001. On average, 4 Wall Street analysts forecast AEMD's earnings for 2027 to be -$2,964,521, with the lowest AEMD earnings forecast at -$4,433,499, and the highest AEMD earnings forecast at -$1,353,248.

In 2028, AEMD is forecast to generate -$670,706 in earnings, with the lowest earnings forecast at -$644,404 and the highest earnings forecast at -$690,433.

If you're new to stock investing, here's how to buy Aethlon Medical stock.

What is AEMD's revenue growth forecast for 2026-2028?

(NASDAQ: AEMD) Aethlon Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.44%.

Aethlon Medical's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast AEMD's revenue for 2026 to be $0, with the lowest AEMD revenue forecast at $0, and the highest AEMD revenue forecast at $0. On average, 4 Wall Street analysts forecast AEMD's revenue for 2027 to be $0, with the lowest AEMD revenue forecast at $0, and the highest AEMD revenue forecast at $0.

In 2028, AEMD is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is AEMD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AEMD) forecast ROA is -10.16%, which is lower than the forecast US Medical Devices industry average of 15.09%.

What is AEMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AEMD) Aethlon Medical's current Earnings Per Share (EPS) is -$51.89. On average, analysts forecast that AEMD's EPS will be -$10.78 for 2026, with the lowest EPS forecast at -$10.52, and the highest EPS forecast at -$10.92. On average, analysts forecast that AEMD's EPS will be -$2.25 for 2027, with the lowest EPS forecast at -$3.37, and the highest EPS forecast at -$1.03. In 2028, AEMD's EPS is forecast to hit -$0.51 (min: -$0.49, max: -$0.53).

What is AEMD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AEMD) forecast ROE is -12.19%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.